Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids. - Wikidata - awgldk - TriplyDB

Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids.

Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids.

http://www.wikidata.org/entity/Q33902032

about

4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis Fenretinide mediated retinoic acid receptor signalling and inhibition of ceramide biosynthesis regulates adipogenesis, lipid accumulation, mitochondrial function and nutrient stress signalling in adipocytes and adipose tissue.Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.LC-MS Based Sphingolipidomic Study on A2780 Human Ovarian Cancer Cell Line and its Taxol-resistant Strain.Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).

P2860

Q28475774-084E857C-86CC-45D0-94EB-F8995762592A Q33897852-26E23B74-97D9-4F8E-A34E-BD9AB24FCD6D Q36006997-75BB076C-E1D9-4A22-AF6F-E4E88AABAB65 Q36604243-48DB63D0-F3C1-4EEE-81E0-8F612A66BC24 Q36874463-408B0E36-BD83-4C08-9CE3-703DDD10C4CE Q37310661-B76836DD-2329-477F-8737-C9CA5676EC36 Q41828412-67F044FF-3843-487F-A7E9-47C8C5DB8AB9 Q47246053-C19FD5BD-AAA1-41CF-9406-27132D963EEA

P2860

Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids.

http://www.wikidata.org/entity/Q33902032

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Sphingolipidomics of A2780 hum ...... ated with synthetic retinoids.

@ast

Sphingolipidomics of A2780 hum ...... ated with synthetic retinoids.

@en

type

label

Sphingolipidomics of A2780 hum ...... ated with synthetic retinoids.

@ast

Sphingolipidomics of A2780 hum ...... ated with synthetic retinoids.

@en

prefLabel

Sphingolipidomics of A2780 hum ...... ated with synthetic retinoids.

@ast

Sphingolipidomics of A2780 hum ...... ated with synthetic retinoids.

@en

P1433

Q33902032-75B5F0A4-63CD-4E56-9B1F-A7BA335F0336

P1476

Q33902032-7B5D31FE-AC2B-45AD-81DD-FCB35FD87151

P2093

Q33902032-8393E416-321A-47F1-9DF2-45A24DAAA9BF

Q33902032-DBBE9F52-7F1B-4496-8022-E558FDAFDD16

Q33902032-F38C696B-774A-4C59-A432-90FA5F09BEB7

P2860

Q33902032-0426F368-7C4B-420F-BFFF-FB83E5A2B3FB

Q33902032-1CE89559-F31F-4DD9-B1AF-7A452A3F7705

Q33902032-2D8B9219-311F-4C5F-8064-9BB9B23DB5EB

Q33902032-45E0B495-2DC8-40BE-8F83-5911F4FF3255

Q33902032-4653BAC1-F885-44C6-A468-6DF1C85CC38B

Q33902032-4E2469DA-3C40-4F35-9335-CB9E78D7065B

Q33902032-543B94C0-BB2D-4CC5-B470-D27F3A1282FA

Q33902032-5580FDD5-2490-4D0D-B32A-06B5AEF0A163

Q33902032-6ABD0A7C-5FAF-4A1D-9E5C-0ECC85987AA3

Q33902032-6DDF0E6E-4A8E-4941-B0D4-0AF84DFBB971

P304

Q33902032-64BF28CA-D8ED-403D-8479-CCD5FA259D30

P31

Q33902032-15B898F8-9FBA-45FC-9875-4903E42D8160

P356

Q33902032-FB41DA90-2F7C-4598-835B-AAD5D75FBF1F

P433

Q33902032-659BDE9A-FAAE-4CAB-B957-51DBACFDEEF2

P478

Q33902032-38E1E6A7-F39F-4828-9D60-6DC55BBA7706

P50

Q33902032-209903AF-B800-4EDB-B145-23E743298922

Q33902032-6B764C23-1A3F-42F5-889B-4AA8B18D3049

Q33902032-D1F1C6DD-7B52-4885-9CCB-988DBB1DF227

Q33902032-FDD034F6-5D5A-4700-94E0-3D6F8AF69A71

P577

Q33902032-14C6D2A7-3DBF-4028-99B9-2B87482D1E0E

P698

Q33902032-3D9B434B-B79E-4E8C-861E-54646F93EF18

P932

Q33902032-844AAB76-DE56-4FA8-AB80-C23870225EE3

P356

P1433

Journal of Lipid Research

P1476

Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids

@en

P2093

Giuditta Illuzzi

http://www.w3.org/2001/XMLSchema#string

Manuela Valsecchi

http://www.w3.org/2001/XMLSchema#string

Vanna Chigorno

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity

Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line

Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide

When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis.

The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma.

Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells.

Mechanisms of fenretinide-induced apoptosis.

Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy.

P304

1832-1840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M004010

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Prinetti

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20194109

http://www.w3.org/2001/XMLSchema#string

P932

2882740

http://www.w3.org/2001/XMLSchema#string